Med Pharma Congress 2020

Theme: Challenges and New ideas in Pharmaceutical and Medicinal Sciences

Med Pharma Congress 2020

Med pharma congress 2020 invites you with regards to the aim of the research, innovation, and scientific aspects. Med Pharma Congress 2020 conference is going to be held at Budapest, Hungary during November 09-10, 2020 .The theme of Med Pharma Congress 2020 conference is "Challenges and New ideas in Pharmaceutical and medicinal Sciences ".

Med pharma Congress 2020 could be an international platform for pharmacists, pharmaceutical business professionals, pharmaceutical marketing professionals and researchers, scientists, clinicians, academics, students and different health care professionals.

The primary goal of Med Pharma Congress 2020 is to promote the latest advancements, research, and developments, explore the challenges in Pharmacy and Pharmaceutical Science and connected areas.

Meet Your Target Market with members across the world focused on learning about Pharmaceutical Sciences and Medicinal Chemistry, Med Pharma Congress 2020 conference is your single best opportunity to reach the largest assemblage of participants from the Pharmaceutical and medicinal community, Find out how innovators are closing the gap between product development and adoption, Debate the potential to greater cross-industry and cross-sector collaboration in the race for faster, cheaper, better cures.

Conduct demonstrations, distribute info, meet with current and potential Scientists, build a splash with new analysis, and receive name recognition at this 2-day event Pharmaceutical Science Chemistry.

World-renowned speakers, the foremost recent techniques, tactics, and also the newest updates in Pharmaceutical Sciences fields are hallmarks of this conference.

Why attend?

Med Pharma Congress 2020 provides a worldwide stage to worldwide systems administration and trading most recent developments in Pharmaceutical Sciences and Medicinal Chemistry. Med Pharma Congress 2020 is a platform which brings together individuals who have an interest in different fields of Pharmaceutical Sciences and Medicinal Chemistry like Pharmacology, Pharmacovigilance, Medicinal Chemistry, analytical and Bioanalytical techniques, and Related Complications, Diseases, and Disorders. Medicinal and pharmaceutical sciences conference helps to explore new practices and provides information on different drugs used to diagnose, cure, treat, or prevent disease. 2oth Medicinal and pharmaceutical Sciences Congress is with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Benefits of Attending Med Pharma Congress 2020:

· Exchange ideas and network with leading researchers, clinicians, and professionals from more than 40 countries.

· Discuss quality initiatives that can be applied in the practice.

·Discuss ways to collaborate in putting quality initiatives in place throughout the medicinal and pharmaceutical sciences.

·Participants can gain direct access to a core audience of professionals and decision-makers and can increase visibility through branding and networking at the conference.

· Learn and discuss key news and challenges with senior level speakers.

·With presentations, panel discussions, roundtable discussions, and workshops, we cover every topic from top to bottom, from global macro issues to strategies to tactical issues

Dear Colleagues,

It is a great pleasure and an honors to extend you a warm invitation to attend the 20thAnnual Medicinal & Pharmaceutical Sciences Congress, to be held on November 09-10, 2020

The Conference will feature a highly reciprocated, adrenalizing and multifaceted program including workshops, plenary sessions as well as oral abstract and poster sessions. Under the theme of ‘Challenges and New ideas in Pharmaceutical and Medicinal Sciences’ the meeting will address the entire patient pathway and look beyond the scientific topics alone.

The Conference will replenish the excellent forum to encourage ideas and establish collaborations as well as to make up extreme discussions. Extended networking opportunities will foster communications between delegates.

We have developed Organizing committees: International, program and local organizing that are populated by outstanding Scientists, Researchers. The program committee is planning a fabulous program ranging across the novel approaches of Case Reports along with its Implications

Sheena Easton

Program Director | Med Pharma Congress 2020

Conference Series LLC LTD

Track 1: Pharmaceutical sciences:

Pharmaceutical Sciences combines a broad range of scientific disciplines such as drug discovery and development and also different therapies. Pharmaceutical sciences can be broadly divided into the following categories, with many specialized fields and category. And categories includes such as Drug Discovery and Design, Drug Delivery, Drug Action, Clinical Sciences, Drug Analysis, Cost Effectiveness of Medicines (Pharma co economics), and Regulatory Affairs.

Conferences: 21st Annual European Pharma Congress May 20-22, 2019 Zurich; Switzerland, 18th International Conference on Pharmaceutics & Novel Drug Delivery Systems May 27-28, 2019 Istanbul, Turkey; USA Medical Conferences; 7th international conference and Exhibition on Pharmacognosy, Phytochemistry and Natural Products June 10-11, 2019 Osaka, Japan; Pharmaceutical Conferences Asia; 7th European Biopharma Congress July 29-30, 2019 Stockholm, Sweden; Medical Conferences Europe; Pharmaceutical Conferences Europe; 5th World Congress on Medicinal Plants and Natural Products Research July 15-16, 2019 Hong Kong; 9th International Conference on Pharmaceutical GMP, GCP & Regulatory Affairs August 02-03, 2019 Chicago, USA; Pharmaceutical Conferences USA; International Medical Conferences; 2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry August 02-03, 2019 Chicago, USA; 24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; Pharmaceutical Conferences Middle East; 4th World Congress on Pharmacology and Toxicology September 11-12, 2019 Singapore

Track 2: Drug Development

Drug development is that the method of developing a brand new drug and delivery to the market once a lead compound has been known through the method of drug discovery. This process involves a specific pre-clinical development process and testing, followed by trials in humans to determine the efficacy of the drug.

Track 3: Pharmacology:

Pharmacology is that the scientific study of drug action on biological systems. It is the study of the interactions between a living organism and drugs, defined as the branch of medicine concerned with the uses, effects, and modes of action of drugs.

Track 4: Toxicology:

Toxicology is that the study of the adverse effects of chemicals or physical agents on living organisms. The scientific study of adverse effects is that occur in the living organisms due to the chemicals. It has a key role in the development of new drugs, which are evaluated for potential toxic effects in pre-clinical studies, clinical trials and post-marketing studies with the aim of ensuring that their benefits outweigh their risks.

Track 5: Pharmacovigilance:

Pharmacovigilance is also known as drug safety, and it is the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse drug reactions.

Track 6: Bio Pharmaceuticals:

Biopharmaceutical Science contains the study of the drug discovery and their development, and along with their properties, both physical and chemical. It conjointly deals with the biological effects of the medicine like onset and period of action beside their intensity within the body. Bio pharmaceutics facilitate in calculative the bio availability and therapeutic activity of the medicine within the body.

Track 7: Pharmacogenomics:

In pharmacogenomics, genomic info is employed to review individual responses to medicine. When a gene variant is associated with a particular drug response in a patient, there is the potential for making clinical decisions based on genetics by adjusting the dosage or choosing a different drug, for example. Scientists assess gene variants affecting an individual's drug response the same way they assess gene variants associated with diseases: by identifying genetic loci associated with known drug responses, and then testing individuals whose response is unknown. Modern approaches include multigene analysis or whole-genome single nucleotide polymorphism (SNP) profiles, and these approaches are just coming into clinical use for drug discovery and development.

Track 8: Analytical and Bio analytical Techniques:

Analytical and Bio analytical Techniques in which it includes analytical methods used for the characterization, release, and stability testing for chemical compounds and for new drugs also as well as the biotechnological/biological product and associated with sciences and pharmaceutical company.

Track 9: Pharmacognosy and Phytochemistry:

Pharmacognosy the branch involved with healthful medicine obtained from plants or alternative natural sources.It is also defined as the study of the physical, chemical, biochemical and biological properties of drugs, drug substances which are origin from natural sources.

Phytochemistry is in the study of phytochemicals in plants and other natural sources. Phytochemicals are chemicals derived from plants. In other words the terms are often used to describe the large number of primary and secondary metabolic compounds found in plants. Phytochemicals have properties such as protection against insect attacks and diseases. They also exhibit a number of protective functions for human beings also.

| International Medical Conferences | medical device conferences

Track 10: Pharmaceutical Preformulation Studies:

Preformulation commences once a fresh synthesized drug shows sufficient pharmacological promise in animal models to warrant analysis in man. These studies should focus on those physicochemical properties of the new compound that could affect drug performance and development of an efficacious dosage form. A thorough understanding of these properties may ultimately provide a rational for formulation design or support the need for molecular modification. This review article focus on the various Preformulation factors which effect the development of new dosage form like drug solubility, partition coefficient, dissolution rate, polymorphic forms and stability

Every drug has intrinsic chemical and physical properties that has been contemplate before development of pharmaceutical formulation. This property provides the framework for drug’s combination with pharmaceutical ingredients. Preformulation studies applied by varied analysis scientists are reviewed. Preformulation studies conduct for fresh synthesized compounds or extracted compound and it offers the knowledge relating to the degradation method, any adverse conditions relevant to the drug, bioavailability, pharmacokinetics and formulation of similar compound and toxicity

Preformulation studies strengthen the scientific foundation of the guidance, provide regulatory relief and conserve resources in the drug development and evaluation process, improve public safety standards, enhance product quality in the fabrication of dosage form. Objective of Preformulation study is to develop the elegant, stable, effective and safe dosage form by establishing kinetic rate profile, compatibility with the other ingredients and establish Physio-chemical parameter of new drug substances.

Polymorphism having crystal and amorphous forms shows totally different chemical physical and therapeutic description of the drug molecule.

Track 11: Industrial Pharmacy:

Industrial Pharmacy mainly deals with the drug research, design, development and also testing, treatments of new medicines, and more over ensuring safety and quality of drugs. And it includes areas relates to different functions in the pharmaceutical industry and having contact with the areas like engineering and economics.

Track 12: Pharma Nanotechnology:

Nanotechnology is a new approach to problem-solving and can be considered as a collection of tools and ideas which can be applied in the pharmaceutical industry. Pharmaceutical Nanotechnology mainly deals with the emerging new technologies in drug developing customized solutions for drug delivery systems. In addition to this, the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signalling and activity.

Track 13: Medicinal Chemistry:

Medicinal chemistry mainly deals with the drug design, optimization and development of chemical compounds. This field includes multidisciplinary topic such as synthesis of potential drugs followed by studies investigating their interactions with biological targets to understand the medicinal effects of the drug, its metabolism and side-effects

Track 14: Clinical Pharmacy:

Clinical pharmacy is that the space of pharmacy involved with the science and follow of rational medication use. And it includes the provision of patient care with the use of medications to optimize the health outcomes of patients.

Track 15: Hospital & Healthcare management:

Healthcare Management may be a totally different system within the management trade. In which it deals with the various field about leadership, management, administration of hospitals, hospital networks, etc. in Hospital Management it is a facility that the services are provided to the hospitals and patients.

Track 15: Regulatory Affairs

Drug Regulatory Affairs refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation. The pharmaceutical law frame, guidelines covering Quality, Safety and Efficacy as well as Health Authorities' attitudes and requirements etc. have a great influence on the drug development process and the success of it. Regulatory affairs professionals deal with these aspects

Track 16: Intellectual Property Rights (IPR)

Industrial property (IP) rights are extremely important for the pharmaceutical industry. The use of the IP system by SMEs in the pharmaceutical industry depends largely on the business strategy of a company, its size, resources, innovative capacity, competitive context and field of expertise. Research-based, innovation-led companies that seek to develop new drugs improve or adapt existing drugs or develop new pharmaceutical/medical equipment or processes, tend to rely heavily on the patent system to ensure they recover the investments incurred in research and development

The medical technology industry is an eminent part of the healthcare sector. It includes, most of all, medical devices which simplify the prevention, diagnosis and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines and implants.

Pharmaceutical Sciences is a stimulating field as it links many scientific disciplines and allows for collaboration with other scientists in researching and developing new drugs. Medicinal chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the processes by which existing pharmaceuticals are made. Medicinal chemists are focused on drug discovery and development and are concerned with the isolation of medicinal agents found in plants, as well as the creation of new synthetic drug compounds.

Drug Discovery volumes continue to rise in the U.S. and chemical market expected to contract this year—As a result, chemical industry capital spending in the U.S. surged 12.1% in 2014 and gained 21.0% in 2015, reaching $43.58 billion and accounting for more than one-half of total construction spending by the manufacturing sector. The association representing US-based chemical producers said that US chemical production (excluding pharmaceuticals) is expected to realize the overall growth of 1.6% in 2016, followed by 4.1% growth next year, and 5.0% in 2018. Average annual gains of over 8% per year in U.S. Chemical industry capital spending are expected through 2018 with only a minor slowdown in subsequent growth expected. By 2021, ACC expects capital spending to reach $70 billion, contributing to four consecutive years of job growth in the industry. American chemistry revenues will exceed $1.0 trillion by 2020.

Pharmacy Council stated that more than 275 new chemical production projects had been announced since 2010 with a total value of more than $170 billion, with a full 49% already complete or under construction; 61% of these are the foreign direct investment. By 2021, U.S. capital spending by the chemical industry will reach $65 billion—more than triple the level of spending at the start of this prolonged cycle in 2010. The trade surplus in chemicals (excluding pharmaceuticals) will grow to $36 billion this year as exports rise by 2% to $132 billion and imports hold steady at $96 billion. Two-way trade between the U.S. and its foreign partners will reach $227 billion this year and will grow steadily over the coming years.

Global:

The global market for medical device technologies reached $458.3 billion in 2015. The market should reach $483.5 billion in 2016. The global market for medical devices technologies reached nearly $521.2 billion in 2017 and should reach $674.5 billion by 2022, at a compound annual growth rate (CAGR) of 5.3% for the period of 2017-2022.

Asia Pacific:

Asia-Pacific medical equipment maintenance market is expected to reach USD 9,054.0 million by 2025 from USD 4,897.9 million in 2017, at the highest of 8.1% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Hong Kong:

Notably, drug spending from the special administrative region's Samaritan Fund - established to finance the health expenditure of low-income people - rose by a significant 12% y-o-y to amount to HKD26 9mn (USD34mn). In aggregate, public funding of pharmaceuticals in Hong Kong rose by 7% y-o-y to amount to HKD5.9bn (USD770mn) for the year.

This growth in pharmaceutical spending in Hong Kong falls in line with our expectations, and we will thus maintain our forecast. We project top-line medicine spending in the special administrative region to grow from HKD9.6bn (USD1.2bn) in 2016, to HKD13.4bn (USD1.7bn) by 2021 and HKD18bn (USD2.3bn) by 2026.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 09-10, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

20^th Medicinal & Pharmaceutical Sciences Congress November 09-10, 2020 Budapest, Hungary

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links